Search results

Page results

• Ward T16 North - Haematology

  T16 North is a specialist adult haematology inpatient ward dedicated to providing high-quality care for patients with a wide range of blood disorders.

• Paediatric Series No 09 - Having total body irradiation

  This page has been written for parents and carers whose child is having total body irradiation (TBI) for leukaemia, lymphoma, or some other rare blood disorder.

• Anti bribery statement - our commitment

  At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.

• Paediatric Series No 10 - Radiotherapy to the spine

  This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).

• Next-generation treatment for multiple myeloma shows early promise

  Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.

• Getting Ready for Transition (GReaT) to secondary school

  Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023. 

• Paediatric Series No.16 - Radiotherapy to the pelvis

  This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.

• UCLH creating a toolkit to make more clinical trials open to young people

  A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.

• Flow-diverting stents (in the treatment of intracranial aneurysms)

  The aim of this page is to provide you with information about flow-diverting stents and how they are used to treat cerebral (brain) aneurysms.

• Peer review shines spotlight on collaborative excellence and challenges at the Red Cell Network HCC

  Every five years, a national Peer Review process casts a supportive but critical eye over red cell services across the UK.